ClinConnect ClinConnect Logo
Search / Trial NCT03598933

Cricopharyngeal Dysfunction in Adults

Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Jul 16, 2018

Trial Information

Current as of May 29, 2025

Unknown status

Keywords

Upper Esophageal Sphincter Botulinum Toxin Cricopharyngeal Dysfunction Cricopharyngeal Botulinum Toxin Injection

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Man or woman whose age older than 18 years
  • Dysphagia with solids and / or liquids
  • Dysfunction of primary or secondary Upper Esophageal Sphincter with indirect video-fibroscopy and / or video-fluoroscopy and / or high resolution pharyngo-oesophageal manometry
  • Subject having at least one injection of botulinum toxin A in the crico-pharyngeal muscle for Upper Esophageal Sphincter dysfunction in the ENT department and cervico-facial surgery of Hautepierre.
  • Subject who has consented to the use of his data from his medical file for the purpose of this research
  • Exclusion Criteria:
  • Myotomy in the first place
  • Refusal of the subject to participate in the study
  • Subject under the protection of justice
  • Subject under guardianship or curatorship

About University Hospital, Strasbourg, France

The University Hospital of Strasbourg, France, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the institution collaborates with a diverse range of healthcare professionals and research teams to explore cutting-edge therapies and treatment modalities. With state-of-the-art facilities and a multidisciplinary approach, the University Hospital of Strasbourg plays a pivotal role in translating scientific discoveries into effective clinical applications, contributing significantly to the advancement of medical knowledge and improved patient outcomes.

Locations

Strasbourg, , France

Patients applied

0 patients applied

Trial Officials

Philippe Schultz, MD

Study Director

University Hospital, Strasbourg, France

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials